|
1
|
Sawicki SG, Sawicki DL, Younker D, Meyer
Y, Thiel V, Stokes H and Siddell SG: Functional and genetic
analysis of coronavirus replicase-transcriptase proteins. PLoS
Pathog. 1:e392005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hong M, Li W, Wang L, Jiang L, Liu L, Zhao
H and Li Q: Identification of a novel transcriptional repressor
(HEPIS) that interacts with nsp-10 of SARS coronavirus. Viral
Immunol. 21:153–162. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Huttlin EL, Ting L, Bruckner RJ, Gebreab
F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier K, et al:
The BioPlex Network: A systematic exploration of the human
interactome. Cell. 162:425–440. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu F and Zhang Y: Expression profile and
promoter analysis of HEPIS. Exp Ther Med. 15:569–575.
2018.PubMed/NCBI
|
|
5
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Proceedings of the National Academy of
Sciences of the United States of America, . Annual subject and
author indexes. Proc Natl Acad Sci USA. 87 (Suppl):S10069–S10240.
1990.
|
|
7
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Pike MC, Spicer DV, Dahmoush L and Press
MF: Estrogens, progestogens, normal breast cell proliferation, and
breast cancer risk. Epidemiol Rev. 15:17–35. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Braun S and Harbeck N: Molecular markers
of metastasis in breast cancer: Current understanding and prospects
for novel diagnosis and prevention. Expert Rev Mol Med. 3:1–14.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Darbre PD and King RJ: Steroid hormone
regulation of cultured breast cancer cells. Cancer Treat Res.
40:307–341. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu F, Wang C, Du J, Sun W, Yan J, Mi D,
Zhang J, Qiao Y, Zhu T and Yang S: DeltaEF1 promotes breast cancer
cell proliferation through down-regulating p21 expression. Biochim
Biophys Acta. 1802:301–312. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hu F, Meng X, Tong Q, Liang L, Xiang R,
Zhu T and Yang S: BMP-6 inhibits cell proliferation by targeting
microRNA-192 in breast cancer. Biochim Biophys Acta.
1832:2379–2390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu F, Gou L, Liu Q, Zhang W, Luo M and
Zhang X: G-patch domain containing 2, a gene highly expressed in
testes, inhibits nuclear factor-KB and cell proliferation. Mol Med
Rep. 11:1252–1257. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu Q, Song YJ, Meng LJ, Hu F, Gou LX, Jia
CH, Tang HM, Wang WJ, Li M, Zhang XJ and Jia MC: Role of LM23 in
cell proliferation and apoptosis and its expression during the
testis development. Asian J Androl. 15:539–544. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hu F, Yang S, Lv S, Peng Y, Meng L, Gou L
and Zhang X: Analysis of AC3-33 gene expression in multiple organ
cancer and adjacent normal tissue by RNA in situ
hybridization. Oncol Lett. 9:2795–2798. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao F, Pan S, Gu Y, Guo S, Dai Q, Yu Y
and Zhang W: Small activating RNA restores the activity of the
tumor suppressor HIC-1 on breast cancer. PLoS One. 9:e864862014.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
R Core Team, . R: A language and
environment for statistical computingR Foundation for Statistical
Computing; Vienna, Austria: 2012, https://www.R-project.org
|
|
18
|
Zhang X, Hao L, Meng L, Liu M, Zhao L, Hu
F, Ding C, Wang Y, He B, Pan Y, et al: Digital gene expression tag
profiling analysis of the gene expression patterns regulating the
early stage of mouse spermatogenesis. PLoS One. 8:e586802013.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huxford T, Malek S and Ghosh G: Structure
and mechanism in NF-kappa B/I kappa B signaling. Cold Spring Harb
Symp Quant Biol. 64:533–540. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Baldwin AS Jr: The NF-kappa B and I kappa
B proteins: New discoveries and insights. Annu Rev Immunol.
14:649–683. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gebel HM, Braun DP, Tambur A, Frame D,
Rana N and Dmowski WP: Spontaneous apoptosis of endometrial tissue
is impaired in women with endometriosis. Fertil Steril.
69:1042–1047. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rawlings JS, Rosler KM and Harrison DA:
The JAK/STAT signaling pathway. J Cell Sci. 117:1281–1283. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Igaz P, Toth S and Falus A: Biological and
clinical significance of the JAK-STAT pathway; lessons from
knockout mice. Inflamm Res. 50:435–441. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
O'Shea JJ, Gadina M and Schreiber RD:
Cytokine signaling in 2002: New surprises in the Jak/Stat pathway.
Cell. 109 (Suppl):S121–S131. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kroon P, Berry PA, Stower MJ, Rodrigues G,
Mann VM, Simms M, Bhasin D, Chettiar S, Li C, Li PK, et al:
JAK-STAT blockade inhibits tumor initiation and clonogenic recovery
of prostate cancer stem-like cells. Cancer Res. 73:5288–5298. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hernandez-Vargas H, Ouzounova M, Le
Calvez-Kelm F, Lambert MP, McKay-Chopin S, Tavtigian SV, Puisieux
A, Matar C and Herceg Z: Methylome analysis reveals Jak-STAT
pathway deregulation in putative breast cancer stem cells.
Epigenetics. 6:428–439. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Plotnikov A, Zehorai E, Procaccia S and
Seger R: The MAPK cascades: Signaling components, nuclear roles and
mechanisms of nuclear translocation. Biochim Biophys Acta.
1813:1619–1633. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Davidson B, Konstantinovsky S, Kleinberg
L, Nguyen MT, Bassarova A, Kvalheim G, Nesland JM and Reich R: The
mitogen-activated protein kinases (MAPK) p38 and JNK are markers of
tumor progression in breast carcinoma. Gynecol Oncol. 102:453–461.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cocolakis E, Lemay S, Ali S and Lebrun JJ:
The p38 MAPK pathway is required for cell growth inhibition of
human breast cancer cells in response to activin. J Biol Chem.
276:18430–18436. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Reichert TE, Kashii Y, Stanson J, Zeevi A
and Whiteside TL: The role of endogenous interleukin-2 in
proliferation of human carcinoma cell lines. Br J Cancer.
81:822–831. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schreiber G and Piehler J: The molecular
basis for functional plasticity in type I interferon signaling.
Trends Immunol. 36:139–149. 2015. View Article : Google Scholar : PubMed/NCBI
|
